Contact Us Contact Us Contact Us

Updated July 2026

Pharma Guide · Buyer Checklist

Updated July 2026

6-Point Checklist Before Choosing a Capsule Manufacturer in India

With over 500 WHO-GMP certified pharmaceutical facilities in India (CDSCO, 2024-25), choosing the right capsule manufacturer in India is not just about price. Six specific checks — including a shell-type distinction most buyers overlook entirely — determine whether your supply chain will pass international drug registration or fail at the regulator’s desk.

  • 10 companies reviewed
  • WHO-GMP verified criteria
  • 14 min read

  • WHO-GMP Status

    Active cert — not expired

  • Sample COA

    real batch data, 24 hours

  • DCGI Approvals

    molecule-level approval

  • COPP on file

    for your target country

  • Grade A/B cleanroom

    sterile injectable

  • Written by

    Bhavya Bhambani

    Content Writer, 9M India

  • Reviewed by

    Manish Agrawal

    MD, 9M India Limited

  • Fact-checked by

    Manish Shah

    Plant Head, 9M India

About 9M India Limited — examples and standards referenced in this guide

9M India Limited is a WHO-GMP certified pharmaceutical manufacturer established in 2009, located in Birkoni, District Mahasamund, Chhattisgarh. The company operates DCGI-approved manufacturing licences for 200+ molecules across hard gelatin and HPMC (Halal-compatible) capsule formats. This guide uses 9M India’s documentation standards as the benchmark — COPP, FSC, COA, and stability data available within 24 hours, exports to 15+ countries.

Why these 6 checks matter — industry context

India manufactures over 70 billion capsule units annually for domestic and export markets (Ministry of Chemicals and Fertilizers, 2024-25). WHO-GMP certified capsule manufacturers are concentrated in Himachal Pradesh (Baddi), Uttarakhand (Haridwar), Gujarat, and Maharashtra. A verification challenge specific to capsules: many facilities that claim broad capability only produce hard gelatin shells, while Middle Eastern and South-East Asian import markets increasingly require Halal-compliant HPMC shells for the same molecules. These six checks are the practical buyer’s verification framework, drawn from the documentation requirements of NAFDAC (Nigeria), MOH UAE, SFDA (Saudi Arabia), and WHO prequalification guidelines.

WHO-GMP Certification

Verify the WHO-GMP certificate expiry date — not just the existence of a certificate

The most common buyer mistake is confirming a WHO-GMP certificate exists without checking whether it's currently valid.

#1 of 6

When sourcing from a capsule manufacturer in India, request the actual WHO-GMP certificate document — not a website badge, not a verbal assurance. The certificate must show the facility name, manufacturing site address, licence number, the dosage forms covered, the issue date, and the expiry date. WHO-GMP certificates in India are issued by the Central Drugs Standard Control Organisation (CDSCO), Ministry of Health and Family Welfare, Government of India, following an on-site inspection.

What is WHO-GMP certification in India?

WHO-GMP (World Health Organization Good Manufacturing Practice) is a pharmaceutical-specific manufacturing standard covering facility design, water purification systems, air handling, personnel hygiene, process validation, analytical quality control, and batch documentation. It is time-limited and requires periodic re-inspection to remain valid. It is distinct from ISO 9001, a general quality management standard not accepted for pharmaceutical export drug registration.

How to verify - step by step

  • Request the actual document: Ask for a PDF or scan of the WHO-GMP certificate on official CDSCO letterhead with authorised signature and stamp.

  • Check the expiry date explicitly: Do not accept a certificate without a visible expiry date.

  • Confirm dosage forms covered: The certificate must list capsule manufacturing specifically.

  • Cross-verify on CDSCO database: Cross-reference the manufacturer’s name and licence number at cdsco.gov.in.

Why this check matters for export

NAFDAC (Nigeria), MOH UAE, and SFDA (Saudi Arabia) all require submission of a valid, unexpired WHO-GMP certificate as part of drug registration. A certificate expired at time of dossier submission is grounds for automatic rejection, adding months to registration timelines. (WHO Technical Report Series No. 986, 2014)

Red flags to watch for

Certificate older than 3 years with no re-inspection documentation · Certificate does not list capsule/oral solid dosage forms · Manufacturer cannot provide certificate within 24 hours · Certificate shows a different manufacturing site address

From Industry Rankings

See how the top 10 capsule manufacturers in India compare on WHO-GMP status

Our editorial ranking compares the top 10 capsule manufacturers in India across all 6 criteria in this guide — WHO-GMP status, shell-type capability, DCGI approvals, export track record, documentation speed, and molecule range breadth.

See the full ranking

DCGI Approval

Confirm DCGI molecule-level approval — the check most buyers miss entirely

WHO-GMP certifies the building. DCGI approves the product. You need both — and most buyers only ask for one.

#2 of 6

The WHO-GMP certificate covers the manufacturing facility as a whole. It does not, by itself, authorise the commercial manufacture of any specific drug product. The Drug Controller General of India (DCGI) issues separate manufacturing licences for individual drug products — specifying the molecule, strength, dosage form, and shell type. A capsule manufacturer in India without a DCGI manufacturing licence for your specific molecule cannot legally manufacture that product for commercial supply, regardless of WHO-GMP status.

Why this distinction matters

Buying from a manufacturer who holds facility WHO-GMP but lacks DCGI product approval means you may receive products manufactured without legal authorisation — a serious regulatory risk for your market registration. This applies separately to each shell type: DCGI approval for a molecule in hard gelatin does not automatically extend to the HPMC version of the same product.

How to verify DCGI molecule-level approval

  • Request the manufacturing licence: Ask for a copy of the DCGI manufacturing licence specifically listing your molecule, strength, and shell type

  • Check the product-specific approval: Your molecule should appear explicitly — not just the general category “capsules”.

  • Confirm shell-type coverage: If you need HPMC, confirm the licence covers HPMC specifically, not just hard gelatin.

  • Verify schedule classification: Confirm the manufacturer holds the correct Schedule classification for your product.

Why this check matters for export

Import regulatory authorities require the dossier to reference a valid, product-specific manufacturing licence — not just a facility-level certificate. A mismatch between the DCGI licence and the submitted dossier is a common cause of registration rejection.

Red flags to watch for

Manufacturer presents facility-level WHO-GMP when asked for product approval · DCGI licence lists only general categories without specific molecules · Manufacturer asks for a purchase order before showing regulatory approvals · HPMC claimed but licence only covers hard gelatin

Shell Type

Confirm hard gelatin vs HPMC capability — not every manufacturer produces both

The shell you don't ask about is the one most likely to block your registration in a Halal-regulated market.

#3 of 6

Hard gelatin capsules use bovine or porcine gelatine shells — the standard for most pharmaceutical markets. HPMC (Hydroxypropyl Methylcellulose) capsules use plant-derived cellulose shells — Halal and Kosher compatible, and required or strongly preferred in UAE, Saudi Arabia, Malaysia, Indonesia, and Pakistan. Not every capsule manufacturer in India produces both — confirm this explicitly before formulation finalisation, not after.

Why shell type is a registration-blocking issue, not a preference

HPMC shells also have lower moisture content (3–7%) versus hard gelatin (12–16%), making them preferred for moisture-sensitive APIs regardless of Halal requirements. Registering a product with the wrong shell type in a market that mandates HPMC can mean a full resubmission of the drug registration dossier.

How to verify — step by step

  • State your target market upfront: Tell the manufacturer explicitly which country you’re registering in before requesting a quote.

  • Request a plant-origin declaration: For HPMC, ask for written confirmation the shell is free from bovine or porcine gelatine.

  • Ask for independent Halal certification: Where possible, verify the shell supplier’s own Halal certification, not just the capsule manufacturer’s claim.

  • Confirm cost delta: HPMC typically carries a 20–30% cost premium over hard gelatin — build this into your costing from the outset.

Shell Type Composition Typical Use Case
Hard Gelatin Bovine/porcine gelatine Standard markets; not accepted in strict Halal-regulated registrations
HPMC Plant-derived cellulose UAE, Saudi Arabia, Malaysia, Indonesia; moisture-sensitive APIs

Why this check matters for export

Several Halal-regulated markets require plant-derived HPMC shells for drug registration approval, particularly for products marketed to observant Muslim consumers. Confirming shell type before formulation avoids a resubmission cycle entirely.

Red flags to watch for

Manufacturer claims HPMC capability without a plant-origin declaration · No independent Halal certification available for the shell · Manufacturer suggests substituting hard gelatin for HPMC after the order is placed · Unable to confirm moisture content specification for the shell type

From the Compare section

WHO-GMP vs ISO 9001 — does certification type affect COA quality?

COA requirements — dissolution, disintegration, moisture content — are pharma-specific standards that only WHO-GMP covers. An ISO 9001 certified capsule manufacturer may not run these tests to pharmacopoeial method at all.

Complete COA
WHO-GMP certified facility

Sterility · Bacterial endotoxin · Particulate matter · Assay · pH — all required and documented per WHO-GMP batch release procedure.

  • All tests mandatory for batch release
ISO 9001 only facility

Sterility · Bacterial endotoxin · Particulate matter · Assay · pH — all required and documented per WHO-GMP batch release procedure.

  • Pharma-specific tests not mandated
Read Full Comparison

Certificate of Analysis

Request a sample Certificate of Analysis within 24 hours — and know what to look for

A genuine capsule manufacturer in India holds batch release data and can share a sample COA immediately. Delay is a red flag.

#4 of 6

A Certificate of Analysis (COA) is the batch-level quality document proving a specific production batch meets all specifications before release. A legitimate capsule manufacturer generates a COA for every batch as part of its WHO-GMP batch release process. A sample COA — real batch data, not a blank template — should be available within 24 hours.

What a complete capsule COA must contain

Beyond assay and batch details, capsule-specific COAs must include dissolution and disintegration data, since these determine how reliably the medicine releases in the body — a parameter that varies meaningfully between shell types and fill formulations.

How to verify — step by step

  • Request a real sample COA: Ask for one from an actual recent batch, not a blank template.

  • Check for numerical values: Every parameter should show the actual result obtained, not just pass/fail.

  • Confirm dissolution data is included: This is the parameter most often omitted from an incomplete COA.

  • Verify the signing authority: COA should be signed by a Qualified Person or pharmacist.

Parameter Why It Matters
Assay (potency) Confirms active ingredient at label strength (95.0–105.0% BP/USP)
Dissolution Confirms release rate at correct time points
Disintegration Confirms capsule breaks down within pharmacopoeial limit
Moisture content Critical for shell integrity, especially HPMC
Uniformity of weight Confirms consistent fill across the batch
Microbial limits Confirms contamination within acceptable range

Why this check matters for export

International regulators require actual numerical results alongside specifications — a COA showing only “Pass” without values is treated as incomplete for dossier submission purposes.

Red flags to watch for

COA not available within 24 hours · COA is a blank template without real batch data · Dissolution/disintegration data missing · COA shows only pass/fail without numerical results

Export Reference

Ask for export references in your specific target country — an existing COPP saves 6–12 months

If the capsule manufacturer has already registered products in your market, your registration timeline shrinks dramatically.

#5 of 6

A Certificate of Pharmaceutical Product (COPP) is an official document issued by CDSCO confirming a specific product is authorised for manufacture and sale in India. Most export drug registration authorities require a valid COPP as part of the registration dossier.

What is a COPP (Certificate of Pharmaceutical Product)?

A COPP is issued under the WHO Certification Scheme on the Quality of Pharmaceutical Products Moving in International Commerce. In India, CDSCO issues COPPs for products manufactured by a DCGI-licensed manufacturer at a WHO-GMP certified facility. If a capsule manufacturer has already exported to your target country and holds an active COPP, their existing dossier can be referenced in your registration application — reducing timelines by 6–12 months. (WHO Technical Report Series No. 986, Annex 10)

How to verify — step by step

  • Ask “Have you previously exported to [country]?”: and request the product name and year of first registration.

  • Ask “Do you hold an active COPP for [country]?”: ask to see the document and confirm it covers your molecule and shell type.

  • Ask “Can you provide a CTD or ACTD dossier?”: export-experienced manufacturers typically hold ready-to-submit dossiers.

  • Confirm shell-type-specific COPP: A COPP for hard gelatin doesn’t automatically cover an HPMC version of the same molecule.

Why this check matters for export

Dossier review queues in Africa and the Middle East are long, and missing documents require complete resubmission — an existing COPP eliminates the initial 30–90 day waiting period entirely.

Red flags Watch For

Vague answers about prior export experience · Cannot name a specific country or product previously registered · COPP offered doesn’t match your specific molecule or shell type · No CTD/ACTD dossier available despite claimed export history

Stability Data

Confirm ICH Zone IVb stability data — capsules are more moisture-sensitive than tablets

A capsule shell that survives an Indian warehouse doesn't automatically survive a Lagos summer.

#6 of 6

For export to Africa, the Middle East, and South Asia, stability data under ICH Zone IVb conditions (30°C/75% relative humidity) is required for drug registration. This matters more for capsules than tablets, since capsule shells — particularly hard gelatin — are meaningfully more moisture-sensitive.

Why capsule stability data needs closer scrutiny

Moisture ingress can cause shell softening, sticking, or brittleness over a product’s shelf life — failure modes that are specific to capsules and won’t necessarily show up in a standard chemical assay. Request stability data that explicitly reports physical shell condition, not just active ingredient assay, at each stability time point.

How to verify — step by step

  • Request Zone IVb-specific data: Ask specifically for 30°C/75% RH data — not just standard 25°C/60% RH.

  • Confirm physical shell observations are included: Not just assay — shell integrity, colour, and brittleness at each interval.

  • Check the shelf-life claim matches the data: A 24-month shelf-life claim needs 24-month real-time data, not just accelerated data extrapolation.

  • Ask for shell-type-specific data: HPMC and hard gelatin degrade differently under humidity — confirm data matches the shell type you’re ordering.

Why this check matters for export

Import authorities in tropical climate zones require real-time and accelerated stability data covering the product’s full claimed shelf life — typically a minimum of 24 months real-time data.

Red Flags to Watch For

Only 25°C/60% RH data offered when Zone IVb is required · Shelf-life claim exceeds available real-time stability data · No physical shell observations included in stability reports · Stability data doesn’t match the specific shell type being ordered

More Pharma Guide

Frequently asked questions

  • How do I verify a WHO-GMP certificate for an Indian capsule manufacturer?

    Request the actual certificate document on CDSCO letterhead showing facility name, manufacturing site address, licence number, dosage forms covered, issue date, and expiry date. Cross-reference independently at cdsco.gov.in using the manufacturer’s name and licence number.

    Reference: Central Drugs Standard Control Organisation (CDSCO), Government of India

  • What is the difference between hard gelatin and HPMC capsules for export?

    Hard gelatin uses bovine/porcine gelatine — standard for most markets. HPMC uses plant-derived cellulose — Halal and Kosher compatible, required or preferred in UAE, Saudi Arabia, Malaysia, Indonesia, and Pakistan. HPMC also suits moisture-sensitive APIs due to lower shell moisture content. Cost premium is typically 20–30%.

  • What should a capsule Certificate of Analysis contain?

    A complete COA must show batch number, manufacturing and expiry dates, assay (95.0–105.0% of label claim), dissolution, disintegration, moisture content, uniformity of weight, microbial limits, and the authorised signature of the releasing Qualified Person — with actual numerical results, not just pass/fail.

    British Pharmacopoeia 2024

  • How long does it take to get a COPP from India for a capsule product?

    A fresh COPP application to CDSCO typically takes 30–90 days from submission. Manufacturers who have previously exported to a specific country typically hold active COPPs that can be provided within 24–48 hours — this is why checking export references (Check 5) matters practically.

    WHO Technical Report Series No. 986, Annex 10

  • Which countries require HPMC capsules instead of hard gelatin?

    UAE, Saudi Arabia, Malaysia, Indonesia, and Pakistan increasingly require or strongly prefer HPMC capsules for Halal pharmaceutical compliance. Requirements vary by product category and specific market — always confirm directly with your target country’s regulatory authority before formulation finalisation.

9M India — passes all 6 checks

Ready to verify 9M India against your checklist?

WHO-GMP certificate, DCGI approval, sample COA, COPP, stability data — all available within 24 hours of your first enquiry.

Send an enquiry
View Capsule range
WhatsApp

WHO-GMP certified · DCGI approved · 15+ export countries · Birkoni, Chhattisgarh · Est. 2009

By Formulation Type
Tablets Capsules Granules & Powders Syrups Suspensions Solutions Ointments Creams Gels Injections Eye Drops Ear Drops External Liquid Dosage
By Therapeutic Segment
Antibiotics Pain Management Cardiovascular Diabetic Care CNS / Neurology Gastrointestinal Respiratory Dermatology Vitamins & Minerals Ophthalmic Paediatrics Anti Infective

Looking for something specific?

At 9M India Limited, trust through quality, transparency, performance.

Get In Touch With Us

Contract Manufacturing

Contract Manufacturing

3rd Party Manufacturing

3rd Party Manufacturing

Institutional Tenders

Institutional Tenders

Generic Medicines

Generic Medicines

OTC Products

OTC Products

Regulatory Services

QC & QA